Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts

BACKGROUND: The combination of EGFR tyrosine kinase inhibitors (TKIs) and chemotherapy is thought to increase treatment efficacy in non‐small‐cell lung cancer (NSCLC). This study investigated the efficacy and potential mechanisms of different combined modes of icotinib plus pemetrexed in EGFR‐mutant...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jiadong, Zhang, Yan, Su, Di, Li, Tao, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119608/
https://www.ncbi.nlm.nih.gov/pubmed/30047610
http://dx.doi.org/10.1111/1759-7714.12818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119608/
https://www.ncbi.nlm.nih.gov/pubmed/30047610
http://dx.doi.org/10.1111/1759-7714.12818

Ejemplares similares